Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.69 -0.06 (-1.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Research & Development (2011 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) posted Research & Development of $1.59 million for Q1 2026, down 27.7% from $2.21 million a year earlier and down 19.8% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Research & Development (2011 - 2026) Analysis & Trends

For FY2025, Oramed Pharmaceuticals' Research & Development came in at $6.38 million, up 0.9% from FY2024.

  • Annual Research & Development shows a four-year compound annual growth rate of -25.7% (FY2021 to FY2025).
  • In prior years, Oramed Pharmaceuticals' Research & Development was $6.32 million in FY2024 (-29.5%), $8.97 million in FY2023 (-67.5%), $27.64 million in FY2022 and $20.99 million in FY2021.
  • Quarterly Research & Development has run from a low of $957,000 in Q3 2023 to a high of $9.18 million in Q2 2022 over five years.
  • On a year-over-year basis, Research & Development increased in three of the last eight quarters, with growth averaging 14.3%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 134.3%; the weakest was Q3 2023, with a decline of 82.1%.
  • According to Business Quant data, Research & Development for the three prior quarters was $1.99 million (Q4 2025), $1.15 million (Q3 2025) and $1.03 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Oramed Pharmaceuticals 196.24 Mn 196.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.59 Mn
Dec 31, 2025 1.99 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 1.03 Mn
Mar 31, 2025 2.21 Mn
Dec 31, 2024 1.46 Mn
Sep 30, 2024 2.24 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 1.18 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 957,000.00
Jun 30, 2023 1.82 Mn
Mar 31, 2023 4.43 Mn
Dec 31, 2022 9.04 Mn
Sep 30, 2022 5.35 Mn
Jun 30, 2022 9.18 Mn
Mar 31, 2022 5.84 Mn
Nov 30, 2019 2.02 Mn
Aug 31, 2019 2.20 Mn
May 31, 2019 3.86 Mn
API Access

Oramed Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ORMP&period=max&api_key=YOUR_API_KEY